Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1980;10(Suppl 2):233S–235S. doi: 10.1111/j.1365-2125.1980.tb01805.x

Arachidonic acid metabolism, pain and hyperalgesia

The mode of action of non-steroidal mild analgesics

Gerald A Higgs
PMCID: PMC1430162  PMID: 7002184

Abstract

1 Cyclo-oxygenase products such as prostaglandins of the E series and prostacyclin produce the hyperalgesia associated with inflammation.

2 These substances may cause pain and incapacity in some inflammatory conditions.

3 Prostaglandin E2 sensitizes the chemical receptors of afferent pain endings to other inflammatory mediators such as bradykinin and histamine.

4 Unstable intermediates formed in the generation of prostaglandins may also play a role in the production of pain.

5 Drugs such as indomethacin and aspirin which are potent inhibitors of prostaglandin biosynthesis may exert their analgesic effect through this mechanism.

Full text

PDF
235S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bevegård S., Orö L. Effect of prostaglandin E1 on forearm blood flow. Scand J Clin Lab Invest. 1969 Jun;23(4):347–353. doi: 10.3109/00365516909081700. [DOI] [PubMed] [Google Scholar]
  2. Collier H. O. A pharmacological analysis of aspirin. Adv Pharmacol Chemother. 1969;7:333–405. [PubMed] [Google Scholar]
  3. Crunkhorn P., Willis A. L. Actions and interactions of prostaglandins administered intradermally in rat and in man. Br J Pharmacol. 1969 May;36(1):216P–217P. [PMC free article] [PubMed] [Google Scholar]
  4. Crunkhorn P., Willis A. L. Cutaneous reactions to intradermal prostaglandins. Br J Pharmacol. 1971 Jan;41(1):49–56. doi: 10.1111/j.1476-5381.1971.tb09934.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ferreira S. H., Moncada S., Vane J. R. Indomethacin and aspirin abolish prostaglandin release from the spleen. Nat New Biol. 1971 Jun 23;231(25):237–239. doi: 10.1038/newbio231237a0. [DOI] [PubMed] [Google Scholar]
  6. Ferreira S. H. Prostaglandins, aspirin-like drugs and analgesia. Nat New Biol. 1972 Dec 13;240(102):200–203. doi: 10.1038/newbio240200a0. [DOI] [PubMed] [Google Scholar]
  7. Ferreira S. H., Vane J. R. Prostaglandins: their disappearance from and release into the circulation. Nature. 1967 Dec 2;216(5118):868–873. doi: 10.1038/216868a0. [DOI] [PubMed] [Google Scholar]
  8. Gillespie A. Prostaglandin-oxytocin enhancement and potentiation and their clinical applications. Br Med J. 1972 Jan 15;1(5793):150–152. doi: 10.1136/bmj.1.5793.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. HORTON E. W. ACTION OF PROSTAGLANDIN E1 ON TISSUES WHICH RESPOND TO BRADYKININ. Nature. 1963 Nov 30;200:892–893. doi: 10.1038/200892b0. [DOI] [PubMed] [Google Scholar]
  10. Hamberg M., Samuelsson B. Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proc Natl Acad Sci U S A. 1974 Sep;71(9):3400–3404. doi: 10.1073/pnas.71.9.3400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hamberg M., Svensson J., Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975 Aug;72(8):2994–2998. doi: 10.1073/pnas.72.8.2994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hamberg M., Svensson J., Wakabayashi T., Samuelsson B. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc Natl Acad Sci U S A. 1974 Feb;71(2):345–349. doi: 10.1073/pnas.71.2.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Higgs E. A., Moncada S., Vane J. R. Inflammatory effects of prostacyclin (PGI2) and 6-oxo-PGF1alpha in the rat paw. Prostaglandins. 1978 Aug;16(2):153–162. doi: 10.1016/0090-6980(78)90018-7. [DOI] [PubMed] [Google Scholar]
  14. Higgs G. A., Cardinal D. C., Moncada S., Vane J. R. Microcirculatory effects of prostacyclin (PGI2) in the hamster cheek pouch. Microvasc Res. 1979 Sep;18(2):245–254. doi: 10.1016/0026-2862(79)90032-3. [DOI] [PubMed] [Google Scholar]
  15. Juhlin L., Michaëlsson G. Cutaneous vascular reactions to prostaglandins in healthy subjects and in patients with urticaria and atopic dermatitis. Acta Derm Venereol. 1969;49(3):251–261. [PubMed] [Google Scholar]
  16. Karim S. Action of prostaglandin in the pregnant woman. Ann N Y Acad Sci. 1971 Apr 30;180:483–498. doi: 10.1111/j.1749-6632.1971.tb53216.x. [DOI] [PubMed] [Google Scholar]
  17. Kuehl F. A., Jr, Humes J. L., Egan R. W., Ham E. A., Beveridge G. C., Van Arman C. G. Role of prostaglandin endoperoxide PGG2 in inflammatory processes. Nature. 1977 Jan 13;265(5590):170–173. doi: 10.1038/265170a0. [DOI] [PubMed] [Google Scholar]
  18. LIM R. K., GUZMAN F., RODGERS D. W., GOTO K., BRAUN C., DICKERSON G. D., ENGLE R. J. SITE OF ACTION OF NARCOTIC AND NON-NARCOTIC ANALGESICS DETERMINED BY BLOCKING BRADYKININ-EVOKED VISCERAL PAIN. Arch Int Pharmacodyn Ther. 1964 Nov 1;152:25–58. [PubMed] [Google Scholar]
  19. Moncada S., Gryglewski R., Bunting S., Vane J. R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976 Oct 21;263(5579):663–665. doi: 10.1038/263663a0. [DOI] [PubMed] [Google Scholar]
  20. Nugteren D. H. Arachidonate lipoxygenase in blood platelets. Biochim Biophys Acta. 1975 Feb 20;380(2):299–307. doi: 10.1016/0005-2760(75)90016-8. [DOI] [PubMed] [Google Scholar]
  21. Smith J. B., Willis A. L. Aspirin selectively inhibits prostaglandin production in human platelets. Nat New Biol. 1971 Jun 23;231(25):235–237. doi: 10.1038/newbio231235a0. [DOI] [PubMed] [Google Scholar]
  22. Solomon L. M., Juhlin L., Kirschenbaum M. B. Prostaglandin on cutaneous vasculature. J Invest Dermatol. 1968 Oct;51(4):280–282. [PubMed] [Google Scholar]
  23. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]
  24. Vane J. R. Prostaglandins as mediators of inflammation. Adv Prostaglandin Thromboxane Res. 1976;2:791–801. [PubMed] [Google Scholar]
  25. WINDER C. V. Aspirin and algesimetry. Nature. 1959 Aug 15;184:494–497. doi: 10.1038/184494a0. [DOI] [PubMed] [Google Scholar]
  26. Willis A. L., Vane F. M., Kuhn D. C., Scott C. G., Petrin M. An endoperoxide aggregator (Lass), formed in platelets in response to thrombotic stimuli: purification, identification and unique biological significance. Prostaglandins. 1974 Dec 25;8(6):453–507. doi: 10.1016/0090-6980(74)90062-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES